Skip to Content

Amphotericin B Cholesteryl Sulfate Complex Injection

Last Updated: October 20, 2014
Status: Discontinued

Products Affected - Description

Amphotec, lyophilized powder, Alkopharma
50 mg vial (NDC 66435-0301-51)
100 mg vial (NDC 66435-0302-01)

Reason for the Shortage

  • Kadmon had acquired Three Rivers Pharmaceuticals in October 2010 and Amphotec was part of the product portfolio. Kadmon sold Amphotec to Alkopharma.
  • Alkopharma was the sole supplier of amphotericin b cholesteryl sulfate lipid complex. The company’s phone is no longer in service. The contracted manufacturer of Amphotec was Ben Venue Laboratories.
  • Ben Venue closed its plant in Bedford, Ohio in July 2014.
  • The shortage of amphotericin b cholesteryl sulfate lipid complex is not affecting other amphotericin formulations.

Available Products

No presentations are available.

Estimated Resupply Dates

Amphotec is not available.

Related Shortages

Updated

October 20, 2014; July 14, 2014; March 24, 2014; January 2, 2014; October 9, 2013; July 11, 2013; April 12, 2013; February 13, 2013; September 10, 2012; July 6, 2012; February 15, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide